Post by
SouthernTierTom on Feb 04, 2021 10:44am
Does anyone have a extra idea for our retail IR list?
Nice words MM!
List of events and recent accomplishments;
* Full FDA approval for wholly-owned EAA diagnostic
* FULL not "EUA" FDA PMX ( blood filtration device ) approval for CV19 in US
* FULL Canada Health PMX approval for CV19
* FULL FDA approval for SAMI device
* FDA approval for DIMI device ( home dialysis pending on FDA home study detail )
* 6.5 MILLION CAD from Baxter for selling partnership arrangement - no strings / no surrender of any company value.
* Pending FULL Canadien DIMI approval with detail to come iminently
* Data from 179 ( 194-16 CAD sites + 1 ) patients identified as usable data from phase 3 trial, to carry substantial weight in TIGRIS approval
* TIGRIS phase 3B/4 confirmatory trial that boasts a 2:1 in favor of our propsed PMX blood filtration device ( used safely and efficacously on over 200,000 patients in Japan and the EU ) * this was a 10 site trial expanded to 15 - Interim analysis H2 2021
* CV19 trial initially 2 sites expanded to 3 ( Conn , NY, Mass ) and expected to look at 75 patients - approaching one year mark - covid trial, expect covid didn't reduce recruitmrent
* Recent finance at 60 cents ( 11 new institutional players ) and 45 cent warrants to come due April/21 to add to adequate cash position
* Consolidation of 10 for 1 approved at last AGM ( by those able to vote )
* January 2021 hire of US invester realtions firm - see next point!
* Awaiting 2020 financials to make the move to a "senior US listing"
* Options are due to be issued in days to weeks - new hire and BoD etc..
* NO other serious competition in our space. NOBODY has the FDA advancement of us when it comes to the treatment of an endotoxemic septic shock patient....
* It looks quite interesting, I know I've been "offered up some alternatives, but I like this one for that "spectralative 3 to 5% of my portfoeleo.
* Always do your own homework and consult a pro in matters $50 USD or $100 CAD
Please feel free to add, perhaps a word or two from the long side?
Bon chance amigos! Let's see what happens when word on this gem escapes the tiny world of Ithaca and specificallty the STIG ( Southern tier investment group ) and goes "viral" ( aka to 100 or so Yanks )
Best to all and let's be friends fellas..we are ALL here for each other to share ideas and learn about our investment.. .
Add to the list...we welcome ALL ; -)
Tommy A Tractor
Comment by
Domino55 on Feb 04, 2021 11:28am
STT - I like your list. I would add the hiring of Dr. Kellum. This is an important advancement too. also, was their an announcement about hiring US investor relations?
Comment by
Domino55 on Feb 04, 2021 2:26pm
Mm - when did they announce that they have an American IR partner. that was not in the recent shareholder presentations. I read the presentation and listened to both and there was no mention of this. if this is true the timing along with Dr. Kellum's hire and the intent to move up to a better US listing makes sense.
Comment by
mercedesman on Feb 04, 2021 2:40pm
Agree. It was never formally announced that I am aware of. It was noted at the bottom of the follwoing NR https://stockhouse.com/news/press-releases/2021/01/06/spectral-medical-to-present-at-the-snn-network-canada-virtual-event-on-january Play where's Walden. Hint: Look towards the bottom. MM
Comment by
Domino55 on Feb 04, 2021 2:47pm
It is at the bottom of the Dr. Kellum NR too. I think many people would miss this. Nobody reads that part of the news release. They must be planning a US IR launch to coincide with an upgraded listing. that would be huge
Comment by
mercedesman on Feb 04, 2021 3:43pm
Hope so ! Long overdue. Another clue is the fact that they plan to restate the FS for 2020 (and comparatives) presumabley to satisfy US listing requirements (GAAP?) This was mentioned in the shareholder update last Dec. "i's need to crossed and "t''s dotted. US plan is important. Not child's play.